Clinical Trial Update: Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient [Phase 2]

View source ↗

Summary

Phase 2 extension study evaluating prevention of acute rejection in kidney transplant patients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: Pfizer | Conditions: Kidney Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2015-07-13